Chemotherapy Induced Neutropenia Market Forecast 2025

Summary
Table Of Content

Market Insights

Chemotherapy induced neutropenia is a very common side effect of cancer chemotherapy, it is treated on the basis of etiology, severity, and duration of the neutropenia. Growing prevalence of different forms of cancer and increasing research and development activities for novel therapeutics are primarily driving the growth of chemotherapy induced neutropenia market globally.

The report titled “Chemotherapy Induced Neutropenia Market – Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall chemotherapy induced neutropenia market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on product, application and different geographical regions. Geographically, the global chemotherapy induced neutropenia market is studied for the following regional markets:

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- Rest of Europe
Asia-Pacific
- China
- Japan
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa
- GCC
- Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global chemotherapy induced neutropenia market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global chemotherapy induced neutropenia market. This report concludes with company profiles section that highlights major information about the key players engaged in global chemotherapy induced neutropenia market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global chemotherapy induced neutropenia market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Chemotherapy Induced Neutropenia Market Snapshot
2.2 Global Chemotherapy Induced Neutropenia Market, by Treatment Type, 2016 (US$ Bn)
2.3 Global Chemotherapy Induced Neutropenia Market Share, by Geography, 2016 (Value %)

Chapter 3 Chemotherapy Induced Neutropenia Market Analysis
3.1 Global Chemotherapy Induced Neutropenia Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Chemotherapy Induced Neutropenia Market

Chapter 4 Global Chemotherapy Induced Neutropenia Market, by Treatment Type
4.1 Overview
4.2 Top 3 Countries
4.3 Antibiotic Therapy
4.4 Colony Stimulating Factor Therapy
4.5 Granulocyte Transfusion
4.6 Splenectomy Procedure

Chapter 5 Global Chemotherapy Induced Neutropenia Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America (Brazil, Mexico, Rest of Latin America)
5.6 Middle East and Africa (GCC, Rest of MEA)

Chapter 6 Company Profiles
6.1 Amgen
6.2 Apotex
6.3 Baxter International
6.4 Biogenomics Limited
6.5 Ligand Pharmaceuticals
6.6 Lupin Limited
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Reddy’s Laboratory
6.10 Sanofi
6.11 Teva Pharmaceuticals Industries

List of Figures

FIG. 1 Chemotherapy Induced Neutropenia Market: Research Methodology
FIG. 2 Global Chemotherapy Induced Neutropenia Market, by Treatmnet Type, 2016 (US$ Bn)
FIG. 3 Global Chemotherapy Induced Neutropenia Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Chemotherapy Induced Neutropenia Market, by Geography, 2016
FIG. 5 Antibiotic Therapy Market for Chemotherapy Induced Neutropenia, 2015 – 2025 (US$ Bn)
FIG. 6 Colony Stimulating Factor Therapy Market for Chemotherapy Induced Neutropenia, 2015 – 2025 (US$ Bn)
FIG. 7 Granulocyte Transfusion for Chemotherapy Induced Neutropenia, 2015 – 2025 (US$ Bn)
FIG. 8 Splenectomy Procedure Market for Chemotherapy Induced Neutropenia, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Chemotherapy Induced Neutropenia Market
TABLE 2 Global Chemotherapy Induced Neutropenia Market, by Treatment Type, 2015 – 2025 (US$ Bn)
TABLE 3 Global Chemotherapy Induced Neutropenia Market, by Top 3 Countries, 2015 – 2025 (US$ Bn)
TABLE 4 Global Chemotherapy Induced Neutropenia Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 5 North America Chemotherapy Induced Neutropenia Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 6 Europe Chemotherapy Induced Neutropenia Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Asia Pacific Chemotherapy Induced Neutropenia Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 8 Latin America Chemotherapy Induced Neutropenia Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Middle East and Africa Chemotherapy Induced Neutropenia Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 10 Amgen: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 Apotex: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Baxter International: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Biogenomics Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Ligand Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Lupin Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Reddy’s Laboratory: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Sanofi: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Teva Pharmaceuticals Industries: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

Frequently ASked Questions:

What is the size of Chemotherapy Induced Neutropenia Market?

The market for Chemotherapy Induced Neutropenia is expected to reach US$ 6.56 Bn in 2028.

What is the Chemotherapy Induced Neutropenia Market CAGR?

The Chemotherapy Induced Neutropenia Market is expected to see significant CAGR growth over the coming years, at 15.0%.

What is the Forecast period considered for Chemotherapy Induced Neutropenia Market?

The report is forecasted from 2019-2027.

What is the base year considered for Chemotherapy Induced Neutropenia Market?

The base year of this report is 2021.

Who are the major players in this market?

Capgemini S.A., EMC Corporation, Hitachi, Ltd., Hewlett-Packard, IBM Corporation, Newgen Software, Inc., Cisco Systems, Inc., SAP SE, SAS Institute, Tata Consultancy Services Ltd. are some of the major players in the global market.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –